Top Medical News
Stephen Padilla, 43 minutes ago
Patients treated with polymer-free drug-eluting coronary stents (DES) show outcomes similar to those treated with durable polymer DES at 10 years, reports a study.
an hour ago
The complication rate is high in transgender men undergoing genital gender affirming surgery with urethral lengthening, which is considered a complex procedure, but no clinically relevant differences in urological functioning have been recorded following treatment of these complications, reports a study.
Audrey Abella, 2 hours ago
The monoclonal antibody galcanezumab may deliver benefit for treatment-resistant* episodic or chronic migraine, according to post hoc results of the CONQUER trial presented at AHS 2020.
Jairia Dela Cruz, 4 hours ago
Foods factor in the management of symptoms of rheumatoid arthritis (RA), and several dietary approaches help by removing staples that promote inflammation or by adding more of anti-inflammatory edibles and altering the gut microbiota, according to a team of researchers.
6 hours ago
Use of glucocorticoid at doses ≥7.5 mg poses an increased risk of incident hypertension among patients with rheumatoid arthritis, a study has found.
Pearl Toh, 17 hours ago
Women who follow a healthy plant-based diet before pregnancy have a lower risk of developing gestational diabetes mellitus (GDM), suggests a large, prospective cohort study presented at ADA 2020 Annual Meeting.
18 hours ago
Patients receiving out-of-hours primary percutaneous coronary intervention (PPCI) endure a slightly longer door-to-balloon time (DTBT) but otherwise have comparable outcomes to those receiving the procedure during regular working hours, a recent study has found.
Special Reports
09 Jul 2020
In this fourth issue, join us as we discover the unique biology Asians have with respect to diabetes. Take a closer look at trials evaluating whether empagliflozin’s cardiovascular and renal benefits – as analysed in Asians – are consistent with the overall trial population, and how it addresses unmet needs.
29 Jun 2020
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illness. On the first day, eminent local and internationalexperts weighed in on the treatment of major depressive disorder (MDD), including in the elderly and incases of coexisting anxiety.
29 Jun 2020
At the Novartis-sponsored VERIFY Soft Launch held at Le Meridien, Kuala Lumpur, two distinguished speakers spoke on the latest updates in glucose-lowering therapy and the benefit of early treatment intensification using combination therapy (ie, vildagliptin/metformin) in the management of T2DM.
Elvira Manzano, 28 Jun 2020
Hyperkalaemia (HK) occurrence and recurrence are frequent in advanced CKD*, creating a perfect storm for cardiovascular events and death, says Professor Juan-Jesus Carrero from the Karolinska Institute, Solna, Sweden, at ERA-EDTA 2020. Given these risks, acutely elevated potassium (K+) should merit clinical attention.
Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Roshini Claire Anthony, 27 Jun 2020

Roxadustat may be a suitable treatment for anaemia in patients with non-dialysis dependent (NDD) chronic kidney disease (CKD), the phase III Dolomites* study showed.

26 Jun 2020
Dapagliflozin 5 mg and 10 mg FC tab
Conference Reports
Pearl Toh, 13 Jul 2020
Women who follow a healthy plant-based diet before pregnancy have a lower risk of developing gestational diabetes mellitus (GDM), suggests a large, prospective cohort study presented at ADA 2020 Annual Meeting.
Roshini Claire Anthony, 13 Jul 2020

The addition of enzalutamide to androgen deprivation therapy (ADT) improved overall survival (OS) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC), demonstrated the phase III PROSPER* trial.

Christina Lau, 13 Jul 2020

Prior treatment with chemotherapy alone, chemotherapy plus immunotherapy, steroids or anticoagulants is associated with an increased risk of death in patients with thoracic cancer who develop coronavirus disease 2019 (COVID-19), new data from the global TERAVOLT (Thoracic Cancers International COVID-10 Collaboration) registry have shown.

Roshini Claire Anthony, 10 Jul 2020

Treatment with ipatasertib plus paclitaxel in the first-line setting demonstrated a trend toward improved overall survival (OS) compared with paclitaxel alone in women with inoperable locally advanced/metastatic triple-negative breast cancer (TNBC), according to final results of the phase II LOTUS trial.

Pearl Toh, 09 Jul 2020
Vitamin D supplementation can reduce the incidence of advanced cancer among older adults, in particular those with a normal BMI but not those who are overweight or obese, suggests the large VITAL* randomized study presented during the ASCO 2020 Meeting.
Audrey Abella, 09 Jul 2020
The anti-interleukin 17A antibody netakimab reduces disease activity and skin manifestations in patients with active psoriatic arthritis (PsA), consequently improving patient-reported outcomes (PROs), analyses of the phase III PATERA trial have shown.
Pearl Toh, 08 Jul 2020
The investigational JAK1* inhibitor filgotinib was noninferior to adalimumab in reducing disease activity in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate response to methotrexate (MTX-IR), according to the FINCH 1 study presented at EULAR 2020 Virtual Meeting.
Product Highlights
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download